retatrutide creator Retatrutide, an experimental weight-loss drug, has not been approved by the FDA. But, doctors and nurse practitioners in clinics across the country are prescribing it anyway, a CBS News investigation found. Adam TikTok influencers fuelling parallel market

Brand-Name FDA-Approved Medications Referenced on altRx altRx's source materials also reference brand-name FDA-approved medications at separate listed price points: Mounjaro: Listed at $1,249 per month per altRx's source materials Ozempic: Listed at $1,149 per month per altRx's source materials Wegovy: Listed at $1,579 per month per altRx's source materials Zepbound: Listed at $1,249 per month per altRx's source materials According to altRx's published trademark notice, Wegovy is FDA-approved for weight loss, and Ozempic is FDA-approved for type 2 diabetes treatment but may be prescribed for weight loss at the discretion of a clinician

Snitman said he saw a Facebook ad for a product with a photo identifying it as a glucose monitor

However, its important to note that using Semaglutide GLP-1 for weight loss in individuals with a BMI below 27 is not currently supported by clinical data or FDA approval

Hepatic Fat and MASH Research: Glucagon receptor activation promotes lipolysis and fatty acid oxidation in the liver, reducing hepatic fat content

They include the following: GLP 1 Weight Loss 35% carbs, 40% protein & 25% fat Calorie Ranges 1200, 1400, 1600, 1800 Creator: Suzanne Fisher, LD RD The GLP-1 Weight Loss meal plans were created specifically to complement GLP-1 medication